Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration.
作者信息
Atak Mehmet Fatih, Farabi Banu, Kalelioglu Mehmet Berati, Rao Babar K
机构信息
Dermatology Department, Tokat State Hospital, Tokat, Turkey.
Internal Medicine Department, Saint Peter's University Hospital-Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
出版信息
J Cosmet Dermatol. 2022 Feb;21(2):435-437. doi: 10.1111/jocd.14607. Epub 2021 Nov 17.
Abstract
摘要
相似文献
1
Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration.
J Cosmet Dermatol. 2022 Feb;21(2):435-437. doi: 10.1111/jocd.14607. Epub 2021 Nov 17.
2
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.
3
Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.
Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.
4
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.
5
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
6
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e26-e28. doi: 10.1111/jdv.17685. Epub 2021 Oct 5.
7
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
8
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?
Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.
9
Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study.
Thromb Res. 2021 Dec;208:1-3. doi: 10.1016/j.thromres.2021.10.002. Epub 2021 Oct 9.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.
引用本文的文献
1
Purpura Annularis Telangiectodes of Majocchi Following a Booster Dose of the Pfizer-BioNTech COVID-19 Vaccine: Coincidence or Correlation?
Cureus. 2025 Feb 1;17(2):e78336. doi: 10.7759/cureus.78336. eCollection 2025 Feb.
2
Therapeutic Approach in Pigmented Purpuric Dermatoses-A Scoping Review.
Int J Mol Sci. 2024 Feb 24;25(5):2644. doi: 10.3390/ijms25052644.
3
A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association?
Vaccines (Basel). 2022 Nov 21;10(11):1972. doi: 10.3390/vaccines10111972.
4
Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients.
Dermatol Ther. 2022 Nov;35(11):e15898. doi: 10.1111/dth.15898. Epub 2022 Oct 10.
5
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
6
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
本文引用的文献
1
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective.
Vaccines (Basel). 2021 Aug 25;9(9):944. doi: 10.3390/vaccines9090944.
2
Cutaneous small-vessel vasculitis following COVID-19 vaccine.
J Cosmet Dermatol. 2021 Nov;20(11):3382-3383. doi: 10.1111/jocd.14452. Epub 2021 Sep 16.
3
Post-Covid cutaneous small-vessel vasculitis with features of Koebnerization.
J Cosmet Dermatol. 2022 Jun;21(6):2307-2308. doi: 10.1111/jocd.14443. Epub 2021 Sep 14.
4
Systemic lupus erythematosus after COVID-19 vaccination: A case report.
J Cosmet Dermatol. 2021 Oct;20(10):3103-3104. doi: 10.1111/jocd.14386. Epub 2021 Aug 21.
5
Guttate flare in a patient with chronic plaque psoriasis following COVID-19 infection: A case report.
J Cosmet Dermatol. 2021 Oct;20(10):3064-3065. doi: 10.1111/jocd.14396. Epub 2021 Aug 20.
6
Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
J Cosmet Dermatol. 2021 Oct;20(10):3080-3084. doi: 10.1111/jocd.14372. Epub 2021 Aug 7.
7
Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine.
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e719-e721. doi: 10.1111/jdv.17497. Epub 2021 Jul 21.
8
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review.
Dermatitis. 2021;32(3):133-139. doi: 10.1097/DER.0000000000000755.
9
Cell infiltrate in progressive pigmented purpura (Schamberg's disease): immunophenotype, adhesion receptors, and intercellular relationships.
Int J Dermatol. 1995 Dec;34(12):846-50. doi: 10.1111/j.1365-4362.1995.tb04419.x.
10
Immunohistologic studies in Schamberg's disease. Evidence for cellular immune reaction in lesional skin.
Arch Dermatol. 1988 Jul;124(7):1058-62.
Zotero 插件